CIPO trademark

GemPharmatech Co., Ltd design mark TMA1335233

RegisteredCIPOFigurative markClass 5Class 10Class 31Class 42

"Design mark TMA1335233" is a figurative mark owned by GemPharmatech Co., Ltd., filed at the CIPO on January 6, 2024. It is registered and covers classes 5, 10, 31 and 42.

View GemPharmatech Co., Ltd. portfolioGet this data via the API
Official CIPO record
GemPharmatech Co., Ltd design mark TMA1335233 trademark as filed
As filed with the CIPO
Status
Registered
Since July 25, 2025
Filed
January 6, 2024
Registered
July 25, 2025
Expires
July 25, 2035
Application no.
2304090
Registration no.
TMA1335233
Office
CIPO
Canadian Intellectual Property Office
Mark type
Figurative mark
4 classes
Ownership

Who owns GemPharmatech Co., Ltd design mark TMA1335233

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

China

31 trademarks in the portfolioView company

Representative

Neomark Ltd.

Neomark Ltd.

Goods and services

What the mark covers

The products and services GemPharmatech Co., Ltd design mark TMA1335233 is filed for, grouped by Nice class.

  • Bacterial poisons; biological preparations for treating tumors; biological tissue cultures for medical purposes; blood culture media for medical and veterinary purposes; human vaccines; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical products for the treatment of rare autoimmune diseases and disorders

  • Containers especially made for medical waste; droppers for medical purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; hypodermic syringes; implantable subcutaneous drug delivery devices; instrument cases for use by doctors; insufflators; medical apparatus and instruments for amplifying nucleic acid DNA and RNA molecules; syringes for injections; syringes for medical purposes; veterinary instruments

  • Bran mash for animal consumption; edible chews for animals; flaxseed meal for animal consumption; foodstuffs for pets; fresh fruit; fresh garden herbs; linseed meal for animal consumption; litter for animals; live laboratory animals; live poultry; live shrimp; mushroom spawn for propagation; rapeseed meal for animal consumption; soy bean meal for animal consumption; unprocessed seaweed for human or animal consumption

  • Chemical research; culturing of cells for scientific research purposes; genetic testing for scientific research purposes; laboratory research analysis in the field of genetic testing; laboratory research in the field of immune sequencing; medical research; preparation of biological samples for testing and analysis in research laboratories; research and development of new products for others; scientific research in the field of genetics; scientific research in the field of immune sequencing; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research laboratories for conducting research in the field of cancer, cancer prevention and cancer diagnosis; scientific research services in the field of cell therapy; scientific research services in the field of gene therapy

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Advertised; Vol.72 Issue 3680
  4. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Search Recorded
  7. Formalized
  8. Created
  9. Filed
FAQ

About GemPharmatech Co., Ltd design mark TMA1335233

Who owns the trademark "Design mark TMA1335233"?

The CIPO trademark "Design mark TMA1335233" (application 2304090) is owned by GemPharmatech Co., Ltd.

What is the status of "Design mark TMA1335233"?

Its status at the CIPO is: registered.

When was "Design mark TMA1335233" registered?

It was registered on July 25, 2025 and is due to expire on July 25, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GemPharmatech Co., Ltd design mark TMA1335233 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb40-05ce-72d9-8c41-ead2a308114d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb40-05ce-72d9-8c41-ead2a308114d",
  "object": "trademark",
  "mark_text": "DESIGN",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2304090",
  "filing_date": "2024-01-06",
  "nice_classes": [
    5,
    10,
    31,
    42
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}